Vanderhyden Lab
Selected publications
Cook DP, Galpin KJC, Rodriguez GM, Shakfa N, Wilson-Sanchez J, Echaibi M, Pereira M, Matuszewska K, Haagsma J, Murshed H, Cudmore AO, Macdonald E, Tone A, Shepherd TG, Petrik JP, Koti M, and BC Vanderhyden. Comparative analysis of syngeneic mouse models of high-grade serous ovarian cancer. Commun. Biol.
Go to publicationLandry DA, Yakubovich E, Cook DP, Fasih S, Upham J and Vanderhyden BC (2022). Metformin prevents age-associated ovarian fibrosis by modulating the immune landscape in female mice. Science Advances
Go to publicationPublications from ORCID
P53 Mutation Induces Epithelial-to-Mesenchymal Transition (EMT) Associated with Stem Cell Properties and Tumorigenesis in Fallopian Tube Cells
2025-10-01 Go to publicationSox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses
2023-12-01 Go to publicationUnveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success
2023-12-01 Go to publicationConventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential
2023-08-01 Go to publicationPreventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics
2022-11-01 Go to publicationNuclear HKII–P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer
2021-07-01 Go to publicationLY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model
2020-07-01 Go to publicationThe polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression
2019-05-01 Go to publicationOvarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
2018-07-01 Go to publicationThe Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
2018-07-01 Go to publication